PubMed:26215578 / 0-215 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T1","span":{"begin":0,"end":10},"obj":"D066260"},{"id":"T2","span":{"begin":0,"end":10},"obj":"D066260"},{"id":"T3","span":{"begin":26,"end":32},"obj":"UBERON:0000310"},{"id":"T4","span":{"begin":33,"end":46},"obj":"D063646"},{"id":"T5","span":{"begin":33,"end":46},"obj":"D063646"},{"id":"T6","span":{"begin":66,"end":72},"obj":"UBERON:0027368"},{"id":"T8","span":{"begin":66,"end":92},"obj":"Q11133"},{"id":"T10","span":{"begin":66,"end":92},"obj":"P21692"},{"id":"T11","span":{"begin":66,"end":92},"obj":"P81563"},{"id":"T12","span":{"begin":66,"end":92},"obj":"Q8GWW6"},{"id":"T14","span":{"begin":66,"end":92},"obj":"PR:000010469"},{"id":"T15","span":{"begin":66,"end":92},"obj":"Q9XSZ5"},{"id":"T16","span":{"begin":66,"end":92},"obj":"P28053"},{"id":"T17","span":{"begin":66,"end":92},"obj":"P13943"},{"id":"T18","span":{"begin":66,"end":92},"obj":"P03956"},{"id":"T13","span":{"begin":66,"end":92},"obj":"D020781"},{"id":"T7","span":{"begin":66,"end":92},"obj":"GO:0004232"},{"id":"T9","span":{"begin":66,"end":92},"obj":"GO:0051405"},{"id":"T20","span":{"begin":138,"end":154},"obj":"UBERON:0000021"},{"id":"T23","span":{"begin":138,"end":161},"obj":"Q9GU69"},{"id":"T21","span":{"begin":138,"end":161},"obj":"D004815"},{"id":"T22","span":{"begin":138,"end":161},"obj":"D004815"},{"id":"T24","span":{"begin":138,"end":161},"obj":"GO:0005154"},{"id":"T30","span":{"begin":163,"end":166},"obj":"Q95ND4"},{"id":"T32","span":{"begin":163,"end":166},"obj":"PR:P01133"},{"id":"T33","span":{"begin":163,"end":166},"obj":"P01133"},{"id":"T34","span":{"begin":163,"end":166},"obj":"PR:P07522"},{"id":"T35","span":{"begin":163,"end":166},"obj":"PR:P01132"},{"id":"T36","span":{"begin":163,"end":166},"obj":"Q9BEA0"},{"id":"T37","span":{"begin":163,"end":166},"obj":"P01132"},{"id":"T38","span":{"begin":163,"end":166},"obj":"P07522"},{"id":"T40","span":{"begin":163,"end":166},"obj":"PR:000006928"},{"id":"T41","span":{"begin":163,"end":166},"obj":"P26224"},{"id":"T43","span":{"begin":163,"end":166},"obj":"Q00968"},{"id":"T31","span":{"begin":163,"end":166},"obj":"CHEBI:140739"},{"id":"T42","span":{"begin":163,"end":166},"obj":"D004815"},{"id":"T44","span":{"begin":163,"end":166},"obj":"D004815"},{"id":"T39","span":{"begin":163,"end":166},"obj":"GO:0005154"},{"id":"T45","span":{"begin":178,"end":185},"obj":"CHEBI:52214"}],"text":"Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.\nBACKGROUND: The epidermal growth factor (EGF) family of ligands has been implicated in promot"}

{"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T1","span":{"begin":0,"end":121},"obj":"DRI_Background"}],"text":"Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.\nBACKGROUND: The epidermal growth factor (EGF) family of ligands has been implicated in promot"}